Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $25,907
31%  
Woo hoo!! And we're now over 31%!! Thank you all very much!! God bless.

Keyword: j147

Brevity: Headers | « Text »
  • Researchers identify the molecular target of J147...nearing clinical trials...Alzheimer's disease

    01/09/2018 12:49:23 PM PST · by Red Badger · 36 replies
    medicalxpress.com ^ | January 9, 2018 | Salk Institute
    The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans. Now, Salk scientists have solved the puzzle of what, exactly, J147 does. In a paper published January 7, 2018, in the journal Aging Cell, they report that the drug binds to a protein found in mitochondria, the energy-generating powerhouses of cells. In turn, they showed, it makes aging cells, mice and flies appear more youthful. "This really glues together everything we know about J147 in terms of...
  • Alzheimer's drug candidate may be first to prevent disease progression

    12/14/2011 3:57:36 PM PST · by decimon · 3 replies
    Salk Institute ^ | December 14, 2011
    Salk scientists develop new drug that improves memory and prevents brain damage in miceA new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS one. When given to mice with Alzheimer's, the drug, known as J147, improved memory and prevented brain damage caused by the disease. The new compound, developed by scientists at the Salk Institute for Biological Studies, could be tested for treatment of the disease in humans in the near future. "J147 enhances memory in both normal and Alzheimer's mice...